Literature DB >> 18490719

A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection.

Mandy L Ford1, Maylene E Wagener, Samantha S Hanna, Thomas C Pearson, Allan D Kirk, Christian P Larsen.   

Abstract

Ag-specific precursor frequency is increasingly being appreciated as an important factor in determining the kinetics, magnitude, and degree of differentiation of T cell responses, and recently was found to play a critical role in determining the relative requirement of CD8(+) T cells for CD28- and CD154-mediated costimulatory signals during transplantation. We addressed the possibility that variations in CD4(+) T cell precursor frequency following transplantation might affect CD4(+) T cell proliferation, effector function, and provision of help for donor-reactive B cell and CD8(+) T cell responses. Using a transgenic model system wherein increasing frequencies of donor-reactive CD4(+) T cells were transferred into skin graft recipients, we observed that a critical CD4(+) T cell threshold precursor frequency was necessary to provide help following blockade of the CD28 and CD154 costimulatory pathways, as measured by increased B cell and CD8(+) T cell responses and precipitation of graft rejection. In contrast to high-frequency CD8(+) T cell responses, this effect was observed even though the proliferative and cytokine responses of Ag-specific CD4(+) T cells were inhibited. Thus, we conclude that an initial high frequency of donor-reactive CD4(+) T cells uncouples T cell proliferative and effector cytokine production from the provision of T cell help.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490719      PMCID: PMC2570960          DOI: 10.4049/jimmunol.180.11.7203

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.

Authors:  Leila Makhlouf; Koji Kishimoto; Rex N Smith; Reza Abdi; Maria Koulmanda; Henry J Winn; Hugh Auchincloss; Mohamed H Sayegh
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

2.  Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection.

Authors:  Benjamin D Ehst; Elizabeth Ingulli; Marc K Jenkins
Journal:  Am J Transplant       Date:  2003-11       Impact factor: 8.086

3.  Critical role of OX40 in CD28 and CD154-independent rejection.

Authors:  Gülçin Demirci; Farhana Amanullah; Reshma Kewalaramani; Hideo Yagita; Terry B Strom; Mohamed H Sayegh; Xian Chang Li
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

4.  IL-2 secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition.

Authors:  Dorothy K Sojka; Denis Bruniquel; Ronald H Schwartz; Nevil J Singh
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 5.  Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction.

Authors:  A S Rosenberg; A Singer
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

6.  Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells.

Authors:  David A Blair; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-07       Impact factor: 11.205

7.  The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.

Authors:  Carole Guillonneau; Cédric Louvet; Karine Renaudin; Jean-Marie Heslan; Michèle Heslan; Laurent Tesson; Caroline Vignes; Cécile Guillot; Yongwon Choi; Lawrence A Turka; Maria-Cristina Cuturi; Ignacio Anegon; Régis Josien
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Role of 4-1BB in allograft rejection mediated by CD8+ T cells.

Authors:  Jun Wang; Zhong Guo; Ying Dong; Oliver Kim; John Hart; Andrew Adams; Christian P Larsen; Robert S Mittler; Kenneth A Newell
Journal:  Am J Transplant       Date:  2003-05       Impact factor: 8.086

9.  Heterologous immunity provides a potent barrier to transplantation tolerance.

Authors:  Andrew B Adams; Matthew A Williams; Thomas R Jones; Nozomu Shirasugi; Megan M Durham; Susan M Kaech; E John Wherry; Thandi Onami; J Gibson Lanier; Kenneth E Kokko; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.

Authors:  Sulaiman A Nanji; Wayne W Hancock; Colin C Anderson; Andrew B Adams; Bin Luo; Colleen D Schur; Rena L Pawlick; Liqing Wang; Anthony J Coyle; Christian P Larsen; A M James Shapiro
Journal:  Am J Transplant       Date:  2004-04       Impact factor: 8.086

View more
  18 in total

1.  Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade.

Authors:  Ivana R Ferrer; Maylene E Wagener; Minqing Song; Allan D Kirk; Christian P Larsen; Mandy L Ford
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

3.  CD28 blockade induces division-dependent downregulation of interleukin-2 receptor alpha.

Authors:  Mandy L Ford; Linda L Stempora; Christian P Larsen
Journal:  Transpl Immunol       Date:  2010-11-10       Impact factor: 1.708

4.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

5.  Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.

Authors:  A D Kirk; A Guasch; H Xu; J Cheeseman; S I Mead; A Ghali; A K Mehta; D Wu; H Gebel; R Bray; J Horan; L S Kean; C P Larsen; T C Pearson
Journal:  Am J Transplant       Date:  2014-03-31       Impact factor: 8.086

Review 6.  Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Expert Opin Biol Ther       Date:  2017-05-30       Impact factor: 4.388

Review 7.  Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations.

Authors:  Mandy L Ford; Christian P Larsen
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

8.  CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8.

Authors:  I R Badell; M C Russell; K Cardona; V O Shaffer; A P Turner; J G Avila; J A Cano; F V Leopardi; M Song; E A Strobert; M L Ford; T C Pearson; A D Kirk; C P Larsen
Journal:  Am J Transplant       Date:  2012-03-28       Impact factor: 8.086

Review 9.  Translating costimulation blockade to the clinic: lessons learned from three pathways.

Authors:  Mandy L Ford; Christian P Larsen
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 10.  Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction.

Authors:  Mandy L Ford; Allan D Kirk; Christian P Larsen
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.